Literature DB >> 14517377

Quantification of the repair process involved in the repair of a cell monolayer using an in vitro model of mechanical injury.

H Lauder1, E E Frost, C R Hiley, T P Fan.   

Abstract

The processes of wound repair were investigated using an in vitro model of mechanical injury on confluent cell monolayers of either human umbilical vein endothelial cells (HUVEC), aortic endothelial (RAEC) or smooth muscle cells (VSMC) of the rat. A mechanical wounder was used to produce 11 parallel (400 microm wide) lesions across the monolayer and the movement of cells into the denuded area was quantified using image analysis. The lesioned area recovered completely in 72h, with proliferation occurring after 24h for endothelial cells and 18h for VSMC, as detected by an increase in cell numbers. The cell migration inhibitor Taxol (1ng/ml) abolished the increase in repair of HUVEC monolayers in the first 24h of repair, while actinomycin D had no effect before 24h but thereafter abolished the further repair which was associated with increased cell numbers. Repair of endothelial cells was accelerated by basic fibroblast growth factor (bFGF), vascular endothelial growth factor or platelet-derived growth factor-BB (PDGF), and in VSMC both bFGF and PDGF increased repair. This simple in vitro model of mechanical injury allows a quantitative study of the repair processes of a previously confluent monolayer and thus is a representation of mechanical damage in vivo. Copyright 1998 Rapid Science Ltd.

Entities:  

Year:  1998        PMID: 14517377     DOI: 10.1023/a:1009006527462

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  9 in total

1.  A Device for Performing Cell Migration/Wound Healing in a 96-Well Plate.

Authors:  Po Ying Poon; Patrick Ying Kit Yue; Ricky Ngok Shun Wong
Journal:  J Vis Exp       Date:  2017-03-07       Impact factor: 1.355

2.  Tanshinol borneol ester, a novel synthetic small molecule angiogenesis stimulator inspired by botanical formulations for angina pectoris.

Authors:  Sha Liao; Liwen Han; Xiaopu Zheng; Xin Wang; Peng Zhang; Jingni Wu; Ruimin Liu; Youlan Fu; Jiaxin Sun; Ximeng Kang; Kechun Liu; Tai-Ping Fan; Shao Li; Xiaohui Zheng
Journal:  Br J Pharmacol       Date:  2019-07-09       Impact factor: 8.739

3.  Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis.

Authors:  P Chiodelli; S Rezzola; C Urbinati; F Federici Signori; E Monti; R Ronca; M Presta; M Rusnati
Journal:  Oncogene       Date:  2017-08-07       Impact factor: 9.867

4.  Sialic acid associated with αvβ3 integrin mediates HIV-1 Tat protein interaction and endothelial cell proangiogenic activation.

Authors:  Paola Chiodelli; Chiara Urbinati; Stefania Mitola; Elena Tanghetti; Marco Rusnati
Journal:  J Biol Chem       Date:  2012-04-23       Impact factor: 5.157

5.  Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms.

Authors:  Shiladitya Sengupta; Lynda A Sellers; Hugh B Matheson; Tai-Ping D Fan
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

6.  Differentially expressed plasma microRNAs and the potential regulatory function of Let-7b in chronic thromboembolic pulmonary hypertension.

Authors:  Lijuan Guo; Yuanhua Yang; Jie Liu; Lei Wang; Jifeng Li; Ying Wang; Yan Liu; Song Gu; Huili Gan; Jun Cai; Jason X-J Yuan; Jun Wang; Chen Wang
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

7.  Extensive Characterization and Comparison of Endothelial Cells Derived from Dermis and Adipose Tissue: Potential Use in Tissue Engineering.

Authors:  Hanneke N Monsuur; Ester M Weijers; Frank B Niessen; Amit Gefen; Pieter Koolwijk; Susan Gibbs; Lenie J van den Broek
Journal:  PLoS One       Date:  2016-11-30       Impact factor: 3.240

8.  Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin.

Authors:  Marco Rusnati; Giulia Paiardi; Chiara Tobia; Chiara Urbinati; Alessio Lodola; Pasqualina D'Ursi; Miriam Corrado; Riccardo Castelli; Rebecca C Wade; Massimiliano Tognolini; Paola Chiodelli
Journal:  Cancer Gene Ther       Date:  2021-08-23       Impact factor: 5.854

9.  Cyclodextrin formulation of the marine natural product pseudopterosin A uncovers optimal pharmacodynamics in proliferation studies of human umbilical vein endothelial cells.

Authors:  Daniel R Day; Suraya Jabaiah; Robert S Jacobs; R Daniel Little
Journal:  Mar Drugs       Date:  2013-08-26       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.